

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.94532702 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.45048426 |
| 3 | respiratory electron transport chain (GO:0022904) | 3.95384291 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.91756039 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 3.91741371 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.91741371 |
| 7 | electron transport chain (GO:0022900) | 3.91736161 |
| 8 | protein neddylation (GO:0045116) | 3.88544641 |
| 9 | signal peptide processing (GO:0006465) | 3.51959031 |
| 10 | extracellular fibril organization (GO:0043206) | 3.40483690 |
| 11 | type B pancreatic cell proliferation (GO:0044342) | 3.36779816 |
| 12 | protein maturation by protein folding (GO:0022417) | 3.30038402 |
| 13 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.25778175 |
| 14 | protein retention in ER lumen (GO:0006621) | 3.20953993 |
| 15 | deoxyribonucleotide catabolic process (GO:0009264) | 3.13277774 |
| 16 | positive regulation of TOR signaling (GO:0032008) | 3.11209903 |
| 17 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.09970509 |
| 18 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.04062861 |
| 19 | proteasome assembly (GO:0043248) | 3.00833762 |
| 20 | base-excision repair, AP site formation (GO:0006285) | 3.00017006 |
| 21 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.99425821 |
| 22 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.99425821 |
| 23 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99305279 |
| 24 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98234363 |
| 25 | GTP biosynthetic process (GO:0006183) | 2.92982423 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 2.92480332 |
| 27 | hydrogen ion transmembrane transport (GO:1902600) | 2.91077066 |
| 28 | protein targeting to mitochondrion (GO:0006626) | 2.90442561 |
| 29 | protein complex biogenesis (GO:0070271) | 2.89376670 |
| 30 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.86584382 |
| 31 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.86584382 |
| 32 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.85217169 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 2.83790721 |
| 34 | fibril organization (GO:0097435) | 2.82821349 |
| 35 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.81090688 |
| 36 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.80815240 |
| 37 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79853372 |
| 38 | deoxyribose phosphate catabolic process (GO:0046386) | 2.79759371 |
| 39 | hydrogen peroxide catabolic process (GO:0042744) | 2.78471971 |
| 40 | adhesion of symbiont to host cell (GO:0044650) | 2.77667627 |
| 41 | virion attachment to host cell (GO:0019062) | 2.77667627 |
| 42 | establishment of protein localization to mitochondrion (GO:0072655) | 2.77146968 |
| 43 | nucleoside diphosphate catabolic process (GO:0009134) | 2.76097135 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 2.74534709 |
| 45 | COPI coating of Golgi vesicle (GO:0048205) | 2.74534709 |
| 46 | response to interferon-beta (GO:0035456) | 2.69972560 |
| 47 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.69821830 |
| 48 | regulation of oxidative phosphorylation (GO:0002082) | 2.66392111 |
| 49 | NADH metabolic process (GO:0006734) | 2.65267165 |
| 50 | inner mitochondrial membrane organization (GO:0007007) | 2.64156910 |
| 51 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.63739555 |
| 52 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.63189607 |
| 53 | viral protein processing (GO:0019082) | 2.63115043 |
| 54 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.62754668 |
| 55 | mannosylation (GO:0097502) | 2.62683291 |
| 56 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.61737355 |
| 57 | neurofilament cytoskeleton organization (GO:0060052) | 2.61412374 |
| 58 | protein heterotrimerization (GO:0070208) | 2.61143689 |
| 59 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.60910788 |
| 60 | nucleotide salvage (GO:0043173) | 2.60227354 |
| 61 | cotranslational protein targeting to membrane (GO:0006613) | 2.59426470 |
| 62 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.59106402 |
| 63 | mitotic nuclear envelope reassembly (GO:0007084) | 2.58458591 |
| 64 | nuclear envelope reassembly (GO:0031468) | 2.58458591 |
| 65 | proton transport (GO:0015992) | 2.58338798 |
| 66 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.58139309 |
| 67 | protein targeting to ER (GO:0045047) | 2.57256595 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.56539452 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.55062939 |
| 70 | protein localization to endoplasmic reticulum (GO:0070972) | 2.54879964 |
| 71 | hydrogen transport (GO:0006818) | 2.54812466 |
| 72 | protein deneddylation (GO:0000338) | 2.54623539 |
| 73 | positive regulation of actin filament depolymerization (GO:0030836) | 2.53825043 |
| 74 | regulation of metalloenzyme activity (GO:0048552) | 2.53273751 |
| 75 | galactose catabolic process (GO:0019388) | 2.53175655 |
| 76 | ATP biosynthetic process (GO:0006754) | 2.52418857 |
| 77 | neuromuscular process controlling posture (GO:0050884) | 2.51971226 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.50320160 |
| 79 | transferrin transport (GO:0033572) | 2.49581447 |
| 80 | creatine metabolic process (GO:0006600) | 2.49185604 |
| 81 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.47241107 |
| 82 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.47241107 |
| 83 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.46292164 |
| 84 | cullin deneddylation (GO:0010388) | 2.45864280 |
| 85 | chaperone-mediated protein transport (GO:0072321) | 2.45004381 |
| 86 | lipopolysaccharide metabolic process (GO:0008653) | 2.43840215 |
| 87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.42428502 |
| 88 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.42428502 |
| 89 | NADH dehydrogenase complex assembly (GO:0010257) | 2.42428502 |
| 90 | deoxyribose phosphate metabolic process (GO:0019692) | 2.42253269 |
| 91 | protein localization to mitochondrion (GO:0070585) | 2.41531895 |
| 92 | oxidative phosphorylation (GO:0006119) | 2.41450475 |
| 93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.40045612 |
| 94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.40045612 |
| 95 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.39852384 |
| 96 | virion assembly (GO:0019068) | 2.39833160 |
| 97 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.38852286 |
| 98 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.38816622 |
| 99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.37098896 |
| 100 | sequestering of actin monomers (GO:0042989) | 2.36792482 |
| 101 | protein insertion into membrane (GO:0051205) | 2.36338441 |
| 102 | oxaloacetate metabolic process (GO:0006107) | 2.35875590 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.35507287 |
| 104 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.35322173 |
| 105 | neuronal action potential propagation (GO:0019227) | 2.35196805 |
| 106 | UTP biosynthetic process (GO:0006228) | 2.34779975 |
| 107 | lipoxygenase pathway (GO:0019372) | 2.33867466 |
| 108 | purine nucleotide salvage (GO:0032261) | 2.32522111 |
| 109 | hydrogen peroxide metabolic process (GO:0042743) | 2.32415785 |
| 110 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.32175686 |
| 111 | pyrimidine nucleoside salvage (GO:0043097) | 2.32165641 |
| 112 | pyrimidine-containing compound salvage (GO:0008655) | 2.32165641 |
| 113 | trivalent inorganic cation transport (GO:0072512) | 2.29374381 |
| 114 | ferric iron transport (GO:0015682) | 2.29374381 |
| 115 | detection of temperature stimulus (GO:0016048) | 2.28480371 |
| 116 | ribosomal small subunit assembly (GO:0000028) | 2.27761043 |
| 117 | mitochondrion degradation (GO:0000422) | 2.27290517 |
| 118 | respiratory chain complex IV assembly (GO:0008535) | 2.26929525 |
| 119 | negative regulation of cation channel activity (GO:2001258) | 2.26808422 |
| 120 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.26381625 |
| 121 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.26081838 |
| 122 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.26081838 |
| 123 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.26071717 |
| 124 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.25906172 |
| 125 | regulation of autophagic vacuole assembly (GO:2000785) | 2.25470464 |
| 126 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.24758755 |
| 127 | viral transcription (GO:0019083) | 2.23573685 |
| 128 | cellular response to nicotine (GO:0071316) | 2.23312337 |
| 129 | positive regulation of mitochondrial fission (GO:0090141) | 2.23078092 |
| 130 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.22906993 |
| 131 | cytochrome complex assembly (GO:0017004) | 2.22763115 |
| 132 | succinate metabolic process (GO:0006105) | 2.19840471 |
| 133 | detection of calcium ion (GO:0005513) | 2.18847835 |
| 134 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.18654648 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.18174382 |
| 136 | metallo-sulfur cluster assembly (GO:0031163) | 2.17843321 |
| 137 | iron-sulfur cluster assembly (GO:0016226) | 2.17843321 |
| 138 | synaptic vesicle exocytosis (GO:0016079) | 2.16728153 |
| 139 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.11669265 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.10587815 |
| 141 | glutathione biosynthetic process (GO:0006750) | 2.09189297 |
| 142 | platelet dense granule organization (GO:0060155) | 2.09171550 |
| 143 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.07481819 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.07096417 |
| 145 | translational termination (GO:0006415) | 2.06883838 |
| 146 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.06745054 |
| 147 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.06155558 |
| 148 | neuronal action potential (GO:0019228) | 2.06129509 |
| 149 | protein targeting to membrane (GO:0006612) | 2.05856015 |
| 150 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.04312840 |
| 151 | cellular response to glucagon stimulus (GO:0071377) | 2.03510871 |
| 152 | phagosome maturation (GO:0090382) | 2.02487762 |
| 153 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.01294495 |
| 154 | glycoside metabolic process (GO:0016137) | 1.99231309 |
| 155 | ribonucleoside diphosphate metabolic process (GO:0009185) | 1.99033089 |
| 156 | cellular copper ion homeostasis (GO:0006878) | 1.98646563 |
| 157 | nonribosomal peptide biosynthetic process (GO:0019184) | 1.97714021 |
| 158 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 1.97036399 |
| 159 | activation of protein kinase A activity (GO:0034199) | 1.96530703 |
| 160 | amyloid precursor protein catabolic process (GO:0042987) | 1.95796154 |
| 161 | purine nucleoside diphosphate metabolic process (GO:0009135) | 1.95574125 |
| 162 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 1.95574125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.78323818 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.42759959 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37087418 |
| 4 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.35441734 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.33674954 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.26214794 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14622048 |
| 8 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.97304237 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.92652466 |
| 10 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90270019 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.86161966 |
| 12 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84262791 |
| 13 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.84156872 |
| 14 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.81763188 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.80445727 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80136597 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69199849 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.64511292 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64254396 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63144021 |
| 21 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.61530728 |
| 22 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.60291303 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.59656918 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56990651 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52438030 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.51521357 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51488814 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.50669476 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50439249 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42729985 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.42418619 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.41647113 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41533249 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38855762 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36358358 |
| 36 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.34422035 |
| 37 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.34383591 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34284756 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33335255 |
| 40 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31711089 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30541989 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29561481 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29159070 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29148380 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28190001 |
| 46 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.26846095 |
| 47 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.25240964 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23179148 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20705290 |
| 50 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.20277820 |
| 51 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.20033849 |
| 52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17733828 |
| 53 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17717979 |
| 54 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17178270 |
| 55 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16482627 |
| 56 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16403236 |
| 57 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15516473 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14921645 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14791427 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14704225 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14520637 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14472178 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.14418792 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13991229 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13497740 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.13103405 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12817000 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12746551 |
| 69 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.12561137 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11486216 |
| 71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11478042 |
| 72 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.11167145 |
| 73 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11115550 |
| 74 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10957897 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10683469 |
| 76 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10163928 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10147091 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10095324 |
| 79 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.07639581 |
| 80 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07339747 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06416887 |
| 82 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.05771480 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05702943 |
| 84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05247426 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05207595 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04196210 |
| 87 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04044623 |
| 88 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03472374 |
| 89 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03472374 |
| 90 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03400355 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 1.03308582 |
| 92 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03193045 |
| 93 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02882723 |
| 94 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02624409 |
| 95 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01812312 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01034487 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00694456 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00362024 |
| 99 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00016139 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99436081 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98679274 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98472812 |
| 103 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98026375 |
| 104 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96791594 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96760029 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96673730 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96295925 |
| 108 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95956332 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.95751772 |
| 110 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.95470502 |
| 111 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95021012 |
| 112 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94389541 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92911587 |
| 114 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.92722970 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92084686 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91291098 |
| 117 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90840886 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89099265 |
| 119 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89094661 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88954035 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88265491 |
| 122 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87643326 |
| 123 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87117002 |
| 124 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86281661 |
| 125 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85211868 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84351957 |
| 127 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.83849047 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83126395 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82436142 |
| 130 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82331419 |
| 131 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.82120043 |
| 132 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.81304959 |
| 133 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80822906 |
| 134 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80657523 |
| 135 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.80479184 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79972673 |
| 137 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.79716469 |
| 138 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79439166 |
| 139 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.78712572 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78492948 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78448517 |
| 142 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.78324141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.61490969 |
| 2 | MP0006054_spinal_hemorrhage | 2.87335574 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 2.83900798 |
| 4 | MP0005503_abnormal_tendon_morphology | 2.47631193 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.42796307 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.28459803 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.27699877 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.22039167 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.20185704 |
| 10 | MP0010030_abnormal_orbit_morphology | 2.19739709 |
| 11 | MP0000013_abnormal_adipose_tissue | 2.18794116 |
| 12 | MP0002736_abnormal_nociception_after | 2.14124584 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.13264388 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.09403158 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.09154463 |
| 16 | MP0003011_delayed_dark_adaptation | 1.96737536 |
| 17 | MP0004858_abnormal_nervous_system | 1.94923514 |
| 18 | MP0002653_abnormal_ependyma_morphology | 1.94809081 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.93072406 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.92070674 |
| 21 | MP0001970_abnormal_pain_threshold | 1.91523235 |
| 22 | MP0005083_abnormal_biliary_tract | 1.89945300 |
| 23 | MP0000751_myopathy | 1.89022135 |
| 24 | MP0000749_muscle_degeneration | 1.83529866 |
| 25 | MP0004270_analgesia | 1.81814287 |
| 26 | MP0005257_abnormal_intraocular_pressure | 1.76470288 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.75792417 |
| 28 | MP0004272_abnormal_basement_membrane | 1.75779699 |
| 29 | MP0006276_abnormal_autonomic_nervous | 1.73314373 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.70761494 |
| 31 | MP0003329_amyloid_beta_deposits | 1.70694036 |
| 32 | MP0001905_abnormal_dopamine_level | 1.67100146 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.66863297 |
| 34 | MP0004043_abnormal_pH_regulation | 1.62059121 |
| 35 | MP0002272_abnormal_nervous_system | 1.55905563 |
| 36 | MP0005275_abnormal_skin_tensile | 1.54686225 |
| 37 | MP0001984_abnormal_olfaction | 1.53655642 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.50922479 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.50674066 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.45020601 |
| 41 | MP0002254_reproductive_system_inflammat | 1.43575790 |
| 42 | MP0002822_catalepsy | 1.41662565 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.38410088 |
| 44 | MP0005508_abnormal_skeleton_morphology | 1.36767127 |
| 45 | MP0002064_seizures | 1.34724668 |
| 46 | MP0003646_muscle_fatigue | 1.33092473 |
| 47 | MP0003724_increased_susceptibility_to | 1.31718616 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.30555103 |
| 49 | MP0009840_abnormal_foam_cell | 1.29861882 |
| 50 | MP0005535_abnormal_body_temperature | 1.29172790 |
| 51 | MP0001664_abnormal_digestion | 1.27954044 |
| 52 | MP0005390_skeleton_phenotype | 1.26095484 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.25951164 |
| 54 | MP0009745_abnormal_behavioral_response | 1.25313706 |
| 55 | MP0003880_abnormal_central_pattern | 1.23490352 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.22922631 |
| 57 | MP0003195_calcinosis | 1.21889817 |
| 58 | MP0006082_CNS_inflammation | 1.20760706 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.20439090 |
| 60 | MP0000747_muscle_weakness | 1.20369135 |
| 61 | MP0004142_abnormal_muscle_tone | 1.19514285 |
| 62 | MP0005165_increased_susceptibility_to | 1.18877820 |
| 63 | MP0001756_abnormal_urination | 1.18734624 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.17558725 |
| 65 | MP0001348_abnormal_lacrimal_gland | 1.16329784 |
| 66 | MP0004147_increased_porphyrin_level | 1.16282541 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.14022409 |
| 68 | MP0000230_abnormal_systemic_arterial | 1.13190989 |
| 69 | MP0004510_myositis | 1.11851835 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.11587617 |
| 71 | MP0001243_abnormal_dermal_layer | 1.10588250 |
| 72 | MP0000920_abnormal_myelination | 1.10148616 |
| 73 | MP0005623_abnormal_meninges_morphology | 1.08859026 |
| 74 | MP0003186_abnormal_redox_activity | 1.08676632 |
| 75 | MP0003866_abnormal_defecation | 1.07784481 |
| 76 | MP0000343_altered_response_to | 1.07043211 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.05996813 |
| 78 | MP0009384_cardiac_valve_regurgitation | 1.04965274 |
| 79 | MP0002638_abnormal_pupillary_reflex | 1.04565819 |
| 80 | MP0004084_abnormal_cardiac_muscle | 1.03133089 |
| 81 | MP0009764_decreased_sensitivity_to | 1.02569058 |
| 82 | MP0001542_abnormal_bone_strength | 1.01838329 |
| 83 | MP0003279_aneurysm | 1.01704513 |
| 84 | MP0009046_muscle_twitch | 1.01431173 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.00391645 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 0.99989035 |
| 87 | MP0000604_amyloidosis | 0.99408107 |
| 88 | MP0005166_decreased_susceptibility_to | 0.98631201 |
| 89 | MP0003436_decreased_susceptibility_to | 0.96938193 |
| 90 | MP0001958_emphysema | 0.96604353 |
| 91 | MP0000681_abnormal_thyroid_gland | 0.96494890 |
| 92 | MP0003075_altered_response_to | 0.96402305 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.96312552 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.94908462 |
| 95 | MP0002067_abnormal_sensory_capabilities | 0.94572027 |
| 96 | MP0003879_abnormal_hair_cell | 0.94564803 |
| 97 | MP0005646_abnormal_pituitary_gland | 0.94496227 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.94031467 |
| 99 | MP0005310_abnormal_salivary_gland | 0.93903296 |
| 100 | MP0003633_abnormal_nervous_system | 0.93665772 |
| 101 | MP0003183_abnormal_peptide_metabolism | 0.93543897 |
| 102 | MP0001529_abnormal_vocalization | 0.92617363 |
| 103 | MP0005330_cardiomyopathy | 0.92194547 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.91358373 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.90101426 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.89854234 |
| 107 | MP0001502_abnormal_circadian_rhythm | 0.89552780 |
| 108 | MP0009785_altered_susceptibility_to | 0.88848693 |
| 109 | MP0004130_abnormal_muscle_cell | 0.88314735 |
| 110 | MP0005670_abnormal_white_adipose | 0.88078396 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87768772 |
| 112 | MP0000358_abnormal_cell_content/ | 0.87510319 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.87329250 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.87272524 |
| 115 | MP0008569_lethality_at_weaning | 0.86795609 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.85889106 |
| 117 | MP0001944_abnormal_pancreas_morphology | 0.85156627 |
| 118 | MP0009278_abnormal_bone_marrow | 0.84661388 |
| 119 | MP0002572_abnormal_emotion/affect_behav | 0.84462430 |
| 120 | MP0005379_endocrine/exocrine_gland_phen | 0.83461328 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.83202363 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.82482148 |
| 123 | MP0002148_abnormal_hypersensitivity_rea | 0.82108635 |
| 124 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80875812 |
| 125 | MP0005023_abnormal_wound_healing | 0.80617889 |
| 126 | MP0002184_abnormal_innervation | 0.80523162 |
| 127 | MP0008874_decreased_physiological_sensi | 0.79658397 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.79570636 |
| 129 | MP0000538_abnormal_urinary_bladder | 0.79456568 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.79435597 |
| 131 | MP0001270_distended_abdomen | 0.79057038 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.78973674 |
| 133 | MP0001666_abnormal_nutrient_absorption | 0.78762604 |
| 134 | MP0003303_peritoneal_inflammation | 0.78194768 |
| 135 | MP0008260_abnormal_autophagy | 0.77908202 |
| 136 | MP0002163_abnormal_gland_morphology | 0.77547522 |
| 137 | MP0002229_neurodegeneration | 0.77453605 |
| 138 | MP0000858_altered_metastatic_potential | 0.73977596 |
| 139 | MP0005075_abnormal_melanosome_morpholog | 0.72951982 |
| 140 | MP0003786_premature_aging | 0.72822127 |
| 141 | MP0005025_abnormal_response_to | 0.72622419 |
| 142 | MP0002060_abnormal_skin_morphology | 0.69693866 |
| 143 | MP0001764_abnormal_homeostasis | 0.69140903 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.68412377 |
| 145 | MP0002933_joint_inflammation | 0.66468246 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.66257549 |
| 147 | MP0003795_abnormal_bone_structure | 0.65881395 |
| 148 | MP0008469_abnormal_protein_level | 0.64694985 |
| 149 | MP0008004_abnormal_stomach_pH | 0.64435841 |
| 150 | MP0003283_abnormal_digestive_organ | 0.63983711 |
| 151 | MP0001663_abnormal_digestive_system | 0.63607058 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.61439436 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.60065278 |
| 154 | MP0000678_abnormal_parathyroid_gland | 0.59710991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.22686273 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.03656687 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.97817432 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.91506453 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.79701764 |
| 6 | Hepatic necrosis (HP:0002605) | 3.76796975 |
| 7 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.62208654 |
| 8 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.62208654 |
| 9 | Acute encephalopathy (HP:0006846) | 3.37009175 |
| 10 | Myokymia (HP:0002411) | 3.36153284 |
| 11 | Hypothermia (HP:0002045) | 3.34438194 |
| 12 | Prolonged neonatal jaundice (HP:0006579) | 3.23059377 |
| 13 | Progressive macrocephaly (HP:0004481) | 3.17341199 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 3.10701306 |
| 15 | Petechiae (HP:0000967) | 3.07272189 |
| 16 | Increased CSF lactate (HP:0002490) | 3.05547058 |
| 17 | Pheochromocytoma (HP:0002666) | 3.03155032 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 2.93567805 |
| 19 | Increased muscle lipid content (HP:0009058) | 2.91350226 |
| 20 | Increased intramyocellular lipid droplets (HP:0012240) | 2.90054755 |
| 21 | Vertebral compression fractures (HP:0002953) | 2.86791700 |
| 22 | Retinal dysplasia (HP:0007973) | 2.76515842 |
| 23 | Dysostosis multiplex (HP:0000943) | 2.74861385 |
| 24 | Protrusio acetabuli (HP:0003179) | 2.69548008 |
| 25 | Lactic acidosis (HP:0003128) | 2.68632813 |
| 26 | Respiratory failure (HP:0002878) | 2.56433818 |
| 27 | Myotonia (HP:0002486) | 2.49797140 |
| 28 | Type I transferrin isoform profile (HP:0003642) | 2.45699510 |
| 29 | Palpitations (HP:0001962) | 2.44318674 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 2.39496677 |
| 31 | Microretrognathia (HP:0000308) | 2.39438363 |
| 32 | Progressive neurologic deterioration (HP:0002344) | 2.35623248 |
| 33 | Follicular hyperkeratosis (HP:0007502) | 2.34278948 |
| 34 | Focal dystonia (HP:0004373) | 2.34226056 |
| 35 | Exercise intolerance (HP:0003546) | 2.33391809 |
| 36 | Exertional dyspnea (HP:0002875) | 2.28477571 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.28395891 |
| 38 | Type II lissencephaly (HP:0007260) | 2.26352385 |
| 39 | Craniofacial dystonia (HP:0012179) | 2.26279452 |
| 40 | Hypokinesia (HP:0002375) | 2.26153227 |
| 41 | Abnormality of magnesium homeostasis (HP:0004921) | 2.24892920 |
| 42 | Cerebral edema (HP:0002181) | 2.22364426 |
| 43 | Cerebral hemorrhage (HP:0001342) | 2.22241264 |
| 44 | Renal Fanconi syndrome (HP:0001994) | 2.21273607 |
| 45 | Hand muscle atrophy (HP:0009130) | 2.21160713 |
| 46 | Joint stiffness (HP:0001387) | 2.20625575 |
| 47 | Purpura (HP:0000979) | 2.20593983 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.18129142 |
| 49 | Opisthotonus (HP:0002179) | 2.17869713 |
| 50 | Redundant skin (HP:0001582) | 2.17788841 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.17776120 |
| 52 | Atrophic scars (HP:0001075) | 2.17707014 |
| 53 | Rough bone trabeculation (HP:0100670) | 2.15986763 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15766803 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.14710711 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.14447169 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14447169 |
| 58 | Abnormality of dentin (HP:0010299) | 2.14324915 |
| 59 | Upper limb amyotrophy (HP:0009129) | 2.13884013 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.13884013 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.13512394 |
| 62 | Oligomenorrhea (HP:0000876) | 2.11062474 |
| 63 | Polyphagia (HP:0002591) | 2.10498153 |
| 64 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10188374 |
| 65 | Hypercortisolism (HP:0001578) | 2.09233810 |
| 66 | Visual hallucinations (HP:0002367) | 2.08332205 |
| 67 | Anxiety (HP:0000739) | 2.07676837 |
| 68 | Delayed gross motor development (HP:0002194) | 2.07262041 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.04986808 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02838593 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02838593 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02838593 |
| 73 | Growth hormone excess (HP:0000845) | 2.02667203 |
| 74 | Testicular atrophy (HP:0000029) | 2.02656922 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01234463 |
| 76 | Beaking of vertebral bodies (HP:0004568) | 2.00716740 |
| 77 | Limb dystonia (HP:0002451) | 1.98731935 |
| 78 | Emotional lability (HP:0000712) | 1.98496683 |
| 79 | Methylmalonic aciduria (HP:0012120) | 1.98071020 |
| 80 | Progressive muscle weakness (HP:0003323) | 1.97296344 |
| 81 | Increased hepatocellular lipid droplets (HP:0006565) | 1.96518909 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96371541 |
| 83 | Neurofibrillary tangles (HP:0002185) | 1.94967617 |
| 84 | Ankle contracture (HP:0006466) | 1.94355410 |
| 85 | Hyperparathyroidism (HP:0000843) | 1.93090216 |
| 86 | Progressive inability to walk (HP:0002505) | 1.92428325 |
| 87 | Torticollis (HP:0000473) | 1.91574560 |
| 88 | Cervical subluxation (HP:0003308) | 1.91376224 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 1.90463203 |
| 90 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90295351 |
| 91 | Stridor (HP:0010307) | 1.89495306 |
| 92 | Poor suck (HP:0002033) | 1.88373448 |
| 93 | Gout (HP:0001997) | 1.86390833 |
| 94 | Abnormal number of erythroid precursors (HP:0012131) | 1.85933075 |
| 95 | Cholecystitis (HP:0001082) | 1.83477392 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.83477392 |
| 97 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83247125 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83224675 |
| 99 | Mucopolysacchariduria (HP:0008155) | 1.83224675 |
| 100 | Increased serum lactate (HP:0002151) | 1.82906248 |
| 101 | Abnormality of the vocal cords (HP:0008777) | 1.82662036 |
| 102 | J-shaped sella turcica (HP:0002680) | 1.82381315 |
| 103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81682025 |
| 104 | Ketoacidosis (HP:0001993) | 1.80169058 |
| 105 | Hepatosplenomegaly (HP:0001433) | 1.80132967 |
| 106 | Muscle stiffness (HP:0003552) | 1.80057380 |
| 107 | Genu recurvatum (HP:0002816) | 1.79756616 |
| 108 | Axonal loss (HP:0003447) | 1.79726838 |
| 109 | Abnormality of the nasal mucosa (HP:0000433) | 1.79107772 |
| 110 | Nuclear cataract (HP:0100018) | 1.78583805 |
| 111 | Optic disc pallor (HP:0000543) | 1.78464805 |
| 112 | Hyperthyroidism (HP:0000836) | 1.78008951 |
| 113 | Myoglobinuria (HP:0002913) | 1.77336129 |
| 114 | Hypomagnesemia (HP:0002917) | 1.77079214 |
| 115 | Fragile skin (HP:0001030) | 1.76684245 |
| 116 | Failure to thrive in infancy (HP:0001531) | 1.76283777 |
| 117 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.75518153 |
| 118 | Slender build (HP:0001533) | 1.75435296 |
| 119 | Nonprogressive disorder (HP:0003680) | 1.75387496 |
| 120 | Spinal rigidity (HP:0003306) | 1.73711844 |
| 121 | Generalized amyotrophy (HP:0003700) | 1.73320386 |
| 122 | Leukodystrophy (HP:0002415) | 1.73311850 |
| 123 | Sudden death (HP:0001699) | 1.73154848 |
| 124 | Adrenal overactivity (HP:0002717) | 1.72810151 |
| 125 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72370815 |
| 126 | Ragged-red muscle fibers (HP:0003200) | 1.71929553 |
| 127 | Calf muscle hypertrophy (HP:0008981) | 1.69638531 |
| 128 | Abnormal pupillary function (HP:0007686) | 1.69189971 |
| 129 | Delusions (HP:0000746) | 1.68671570 |
| 130 | CNS demyelination (HP:0007305) | 1.68377441 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68338494 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68338494 |
| 133 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68338494 |
| 134 | Loss of speech (HP:0002371) | 1.67423127 |
| 135 | Soft skin (HP:0000977) | 1.67025027 |
| 136 | Nonimmune hydrops fetalis (HP:0001790) | 1.66490768 |
| 137 | Atonic seizures (HP:0010819) | 1.65832657 |
| 138 | Hypokalemic alkalosis (HP:0001949) | 1.65418220 |
| 139 | Abnormality of renal resorption (HP:0011038) | 1.64880866 |
| 140 | Hyperactive renin-angiotensin system (HP:0000841) | 1.64851223 |
| 141 | Exercise-induced myalgia (HP:0003738) | 1.64413238 |
| 142 | Ulnar claw (HP:0001178) | 1.64286722 |
| 143 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.64243734 |
| 144 | Abnormal protein glycosylation (HP:0012346) | 1.63670497 |
| 145 | Abnormal glycosylation (HP:0012345) | 1.63670497 |
| 146 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.63670497 |
| 147 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.63670497 |
| 148 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.63272399 |
| 149 | Rapidly progressive (HP:0003678) | 1.62971066 |
| 150 | Patent foramen ovale (HP:0001655) | 1.62341158 |
| 151 | Amyloidosis (HP:0011034) | 1.61243483 |
| 152 | Flat capital femoral epiphysis (HP:0003370) | 1.61234544 |
| 153 | Dysautonomia (HP:0002459) | 1.59004969 |
| 154 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.58936004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 3.37684397 |
| 2 | TESK2 | 2.91803629 |
| 3 | VRK2 | 2.91789344 |
| 4 | BCKDK | 2.83068515 |
| 5 | MAP3K12 | 2.78064597 |
| 6 | NME2 | 2.74228071 |
| 7 | ERN1 | 2.68392335 |
| 8 | MYLK | 2.41538929 |
| 9 | CAMKK2 | 2.17706305 |
| 10 | CDK19 | 2.07711775 |
| 11 | MAPKAPK3 | 2.05590098 |
| 12 | MUSK | 2.04887542 |
| 13 | NTRK1 | 1.87462352 |
| 14 | GRK5 | 1.85889800 |
| 15 | PIM2 | 1.79142377 |
| 16 | EPHB2 | 1.68286692 |
| 17 | PHKG1 | 1.63180945 |
| 18 | PHKG2 | 1.63180945 |
| 19 | MAPK15 | 1.58803998 |
| 20 | PINK1 | 1.57521640 |
| 21 | NME1 | 1.53362960 |
| 22 | MAPKAPK5 | 1.52211737 |
| 23 | KSR2 | 1.51063709 |
| 24 | TIE1 | 1.50753037 |
| 25 | MAP3K9 | 1.48041315 |
| 26 | WNK4 | 1.40274836 |
| 27 | MAP3K2 | 1.37804475 |
| 28 | MAP3K11 | 1.36336183 |
| 29 | STK39 | 1.34415154 |
| 30 | LMTK2 | 1.34387376 |
| 31 | TAOK2 | 1.31379306 |
| 32 | GRK7 | 1.26690937 |
| 33 | CSNK1G2 | 1.25557981 |
| 34 | MAP2K2 | 1.24604799 |
| 35 | MAP3K1 | 1.24453099 |
| 36 | CSNK1G1 | 1.20314284 |
| 37 | MAP2K3 | 1.19896490 |
| 38 | PAK4 | 1.18789584 |
| 39 | BRAF | 1.14175999 |
| 40 | OXSR1 | 1.12622501 |
| 41 | STK16 | 1.12017660 |
| 42 | CSNK1A1L | 1.10724867 |
| 43 | ZAP70 | 1.10503971 |
| 44 | LIMK1 | 1.09192823 |
| 45 | EPHB1 | 1.07937726 |
| 46 | PRKD2 | 1.07004838 |
| 47 | PRKD3 | 1.04163395 |
| 48 | TRIB3 | 1.03659437 |
| 49 | TBK1 | 1.02369117 |
| 50 | TNK2 | 0.95481855 |
| 51 | DAPK3 | 0.95300772 |
| 52 | CAMK2G | 0.94414383 |
| 53 | PAK1 | 0.93627904 |
| 54 | MAP3K3 | 0.93247982 |
| 55 | DYRK2 | 0.91792649 |
| 56 | LRRK2 | 0.91775099 |
| 57 | NTRK3 | 0.89617244 |
| 58 | MAP2K7 | 0.85958991 |
| 59 | ILK | 0.85685918 |
| 60 | DAPK2 | 0.85115509 |
| 61 | HIPK2 | 0.85045212 |
| 62 | GRK1 | 0.84632459 |
| 63 | PTK2 | 0.83388557 |
| 64 | PRKCI | 0.83016136 |
| 65 | TGFBR2 | 0.82921918 |
| 66 | GRK6 | 0.82638367 |
| 67 | MINK1 | 0.82212575 |
| 68 | MAP2K1 | 0.80397437 |
| 69 | CAMK2D | 0.79870709 |
| 70 | KDR | 0.78508807 |
| 71 | MATK | 0.78358905 |
| 72 | MAP3K13 | 0.78201591 |
| 73 | MAP4K2 | 0.76665279 |
| 74 | MST4 | 0.76641424 |
| 75 | CAMK1 | 0.75937569 |
| 76 | BMX | 0.75379949 |
| 77 | TLK1 | 0.73434717 |
| 78 | RET | 0.72638176 |
| 79 | ADRBK2 | 0.71994167 |
| 80 | PRKG2 | 0.71443341 |
| 81 | MAP2K6 | 0.71278961 |
| 82 | FER | 0.71220659 |
| 83 | EPHA3 | 0.70813325 |
| 84 | MAP2K4 | 0.70657557 |
| 85 | PAK6 | 0.70381723 |
| 86 | TAOK1 | 0.70049705 |
| 87 | SCYL2 | 0.70015939 |
| 88 | DDR2 | 0.69106854 |
| 89 | CAMKK1 | 0.67317671 |
| 90 | IRAK3 | 0.66432798 |
| 91 | CAMK2B | 0.66020099 |
| 92 | INSRR | 0.65785597 |
| 93 | AURKA | 0.65713621 |
| 94 | IRAK1 | 0.65630267 |
| 95 | TESK1 | 0.65469338 |
| 96 | TYK2 | 0.64880609 |
| 97 | MAPK12 | 0.62007280 |
| 98 | PDPK1 | 0.60293892 |
| 99 | RPS6KA5 | 0.59683616 |
| 100 | PIK3CG | 0.59150754 |
| 101 | PRKCE | 0.58302661 |
| 102 | ADRBK1 | 0.58142769 |
| 103 | EPHA2 | 0.55359101 |
| 104 | IKBKB | 0.55179858 |
| 105 | PRKCH | 0.54470161 |
| 106 | FES | 0.54365317 |
| 107 | MAP4K1 | 0.54054294 |
| 108 | BMPR1B | 0.53324742 |
| 109 | FLT3 | 0.52830349 |
| 110 | RAF1 | 0.51452067 |
| 111 | SYK | 0.50598492 |
| 112 | CDK5 | 0.49496604 |
| 113 | UHMK1 | 0.49379043 |
| 114 | PDK2 | 0.48824915 |
| 115 | CSNK1G3 | 0.48275079 |
| 116 | CAMK2A | 0.47823104 |
| 117 | SIK3 | 0.46435747 |
| 118 | MOS | 0.45874410 |
| 119 | DAPK1 | 0.45519731 |
| 120 | RPS6KA2 | 0.45481610 |
| 121 | CDK14 | 0.45180733 |
| 122 | IRAK2 | 0.43889382 |
| 123 | VRK1 | 0.43841919 |
| 124 | PRKCG | 0.43448502 |
| 125 | PTK2B | 0.42696443 |
| 126 | SGK494 | 0.41721875 |
| 127 | SGK223 | 0.41721875 |
| 128 | TTN | 0.41310388 |
| 129 | PRKD1 | 0.41307651 |
| 130 | TEC | 0.40259854 |
| 131 | ABL2 | 0.40051931 |
| 132 | PDK1 | 0.39853750 |
| 133 | PRKCD | 0.39503167 |
| 134 | MAP3K4 | 0.39485289 |
| 135 | ROCK1 | 0.39291253 |
| 136 | ROCK2 | 0.38925634 |
| 137 | BUB1 | 0.36995004 |
| 138 | CDK11A | 0.34892701 |
| 139 | DYRK1B | 0.34664977 |
| 140 | PAK3 | 0.34426681 |
| 141 | PLK2 | 0.34114214 |
| 142 | ZAK | 0.33016275 |
| 143 | KIT | 0.32725820 |
| 144 | PRKCA | 0.31624300 |
| 145 | GSK3A | 0.30866551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.47805314 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.85788900 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.28279502 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 2.94419736 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.58922056 |
| 6 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.47547239 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.34951045 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28904830 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.25541688 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.21012705 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.10164085 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08584385 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96369217 |
| 14 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.69812865 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68580453 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.57596607 |
| 17 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.51452537 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50282371 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45528247 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.41357162 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32711569 |
| 22 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.32333565 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.28572978 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23702243 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21937497 |
| 26 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20307236 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16535738 |
| 28 | Proteasome_Homo sapiens_hsa03050 | 1.13300663 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12361343 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11756119 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08659724 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.06926640 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05855014 |
| 34 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.02449409 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.01286894 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00305389 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99328539 |
| 38 | Base excision repair_Homo sapiens_hsa03410 | 0.97910783 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97437994 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96689340 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95961042 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94966397 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.94527830 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92013350 |
| 45 | GABAergic synapse_Homo sapiens_hsa04727 | 0.90917873 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 0.90231412 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85256299 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81674397 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81456284 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81224999 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80585151 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.80451813 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79688576 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 0.79567515 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77914377 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77831142 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77587888 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.76787260 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74669960 |
| 60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74667498 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74592082 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74572373 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73074092 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69424778 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.68849621 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67858331 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.67481310 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66407470 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64179727 |
| 70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61562648 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60555131 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60464857 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59596502 |
| 74 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59003863 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58819426 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57549728 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56712889 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.56594054 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54218442 |
| 80 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54072426 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53045105 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52892726 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52142450 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51690698 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51541194 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51453903 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51053647 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51002850 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49992788 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49867294 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.49644653 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49638311 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48195737 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48002569 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47678462 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.45892387 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45223828 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44892747 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44501481 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43748124 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43624411 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42604342 |
| 103 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41876062 |
| 104 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40720050 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40031177 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39056460 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.38043715 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.36757580 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.34321192 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34318633 |
| 111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34273698 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.33878506 |
| 113 | Allograft rejection_Homo sapiens_hsa05330 | 0.32424231 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.32251086 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31718550 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31406129 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31190072 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31038485 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30797526 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30728765 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30377284 |
| 122 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29282009 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29084648 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.28106228 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28086817 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26431508 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26397811 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26341358 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.25734495 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.25609552 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25601423 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.25593577 |
| 133 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20959491 |
| 134 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20599699 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.18783483 |
| 136 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18225886 |
| 137 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.18082232 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16644470 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.16514689 |
| 140 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14453674 |

